Decipher Labs

Decipher_Labs03 May 2024

Pharmaceuticals

₹

-0.22 (-1.36%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Decipher Labs

Decipher Labs

Pharmaceuticals

Decipher_Labs03 May 2024

₹

-0.22 (-1.36%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
30-Apr-2024	BC	With reference to the subject cited, this is to inform the Exchange that the Board of Directors of Decipher Labs Limited at its meeting held on Tuesday, the 30th day of April, 2024 at 4.30 P.M. at th	30-Apr-2024
06-Feb-2024	BC	Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Unaudited Financial results (Standalone an	14-Feb-2024
02-Nov-2023	BC	Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve 1. Unaudited Financial results (Standalone an	10-Nov-2023
04-Sep-2023	BC	Outcome of Board Meeting held on 04.09.2023. Intimation of book closure and cut- off date for the 37th annual general meeting of Decipher Labs Limited (As per BSE Announcement Dated on 08/09/20	30-Sep-2023
04-Sep-2023	BC	Outcome of Board Meeting held on 04.09.2023.	29-Sep-2023

No Rights has been declared by Decipher_Labs

Book Closure

Record Date	Split Date	Purpose
30-Apr-2024	-	With reference to the subject cited, this is to inform the Exchange that the Board of Directors of Decipher Labs Limited at its meeting held on Tuesday, the 30th day of April, 2024 at 4.30 P.M. at th
14-Feb-2024	-	Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Unaudited Financial results (Standalone an
10-Nov-2023	-	Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve 1. Unaudited Financial results (Standalone an
30-Sep-2023	-	Outcome of Board Meeting held on 04.09.2023. Intimation of book closure and cut- off date for the 37th annual general meeting of Decipher Labs Limited (As per BSE Announcement Dated on 08/09/20
29-Sep-2023	-	Outcome of Board Meeting held on 04.09.2023.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Decipher Labs Ltd ₹15.91(-0.22/-1.36%)	15.91	-0.22	16.07	-19.28	0.00	1.85
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.17	0.00	0.00	0.13	0.03	0.12
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.17	0.00	0.00	0.13	0.03	0.12
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.01	0.01	0.00	0.01	0.01
Total Income	0.18	0.01	0.01	0.13	0.04	0.13
Total Expenditure	0.08	0.09	0.11	0.46	2.35	0.14
PBIDT	0.10	-0.09	-0.10	-0.33	-2.31	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.10	-0.09	-0.10	-0.33	-2.31	0.00
Depreciation	0.00	0.00	0.00	0.01	0.01	0.01
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	-0.02	0.02	0.03	0.00	0.00
Reported Profit After Tax	0.09	-0.07	-0.12	-0.37	-2.33	-0.02
Extra-ordinary Items	0.00	0.00	0.00	0.00	-2.24	0.00
Adjusted Profit After Extra-ordinary item	0.09	-0.07	-0.12	-0.37	-0.09	-0.02

EPS (Unit Curr.)	0.09	-0.07	-0.12	-0.36	-2.30	-0.02
EPS (Adj) (Unit Curr.)	0.09	-0.07	-0.12	-0.36	-2.30	-0.02
Calculated EPS (Unit Curr.)	0.09	-0.07	-0.12	-0.36	-2.30	-0.02
Calculated EPS (Adj) (Unit Curr.)	0.09	-0.07	-0.12	-0.36	-2.30	-0.02
Calculated EPS (Ann.) (Unit Curr.)	0.37	-0.30	-0.48	-1.45	-9.22	-0.08
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.37	-0.30	-0.48	-1.45	-9.22	-0.08
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.10	10.10	10.10	10.10	10.10	10.10
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	58.82	0.00	0.00	-253.85	-7700.00	0.00
PBDTM(%)	58.82	0.00	0.00	-253.85	-7700.00	0.00
PATM(%)	52.94	0.00	0.00	-284.62	-7766.67	-16.67

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	8.29	7.49	9.51	9.78	11.06	12.12
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	8.29	7.49	9.51	9.78	11.06	12.12
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.14	0.01	0.15	-2.31	2.66
Total Income	8.29	7.63	9.51	9.93	8.75	14.78
Total Expenditure	8.16	9.66	9.65	13.63	16.26	12.99
PBIDT	0.13	-2.03	-0.13	-3.70	-7.51	1.79
Interest	0.00	0.00	0.01	0.07	0.13	0.12
PBDT	0.13	-2.03	-0.14	-3.77	-7.64	1.68
Depreciation	0.12	0.11	0.11	0.12	0.11	0.10
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.38	0.01	0.38
Deferred Tax	0.00	-0.20	0.70	0.00	0.00	0.00
Reported Profit After Tax	0.01	-1.94	-0.95	-4.27	-7.75	1.19
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	0.01	-1.94	-0.95	-4.27	-7.75	1.19

Extra-ordinary Items	0.00	0.00	0.00	0.00	-2.24	0.00
Adjusted Profit After Extra-ordinary item	0.01	-1.94	-0.95	-4.27	-5.51	1.19

EPS (Unit Curr.)	0.01	-1.92	-0.94	-4.23	-7.68	1.18
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.10	10.10	10.10	10.10	10.10	10.10

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	1.57	-27.10	-1.37	-37.83	-67.90	14.77
PBDTM(%)	1.57	-27.10	-1.47	-38.55	-69.08	13.86
PATM(%)	0.12	-25.90	-9.99	-43.66	-70.07	9.82

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.10	10.10	10.10	10.10	8.00	8.00
Reserves Total	-1.20	1.42	1.06	0.97	-5.50	-5.88
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	8.90	11.52	11.16	11.07	2.50	2.12
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.14	0.23	0.14	0.13
Total Debt	0.00	0.00	0.14	0.23	0.14	0.13
Total Liabilities	8.90	11.52	11.30	11.30	2.64	2.25
APPLICATION OF FUNDS :
Gross Block	0.24	0.43	0.30	0.11	0.01	0.00
Less : Accumulated Depreciation	0.12	0.09	0.04	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.12	0.34	0.26	0.11	0.01	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	8.66	8.66	8.41	8.41	0.05	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.04	0.04	0.32	0.32	0.10
Sundry Debtors	0.13	0.22	0.41	0.17	3.04	0.59
Cash and Bank	0.06	0.05	0.02	0.03	0.02	0.02
Loans and Advances	0.00	2.29	2.25	2.60	2.41	2.25
Total Current Assets	0.18	2.60	2.73	3.13	5.78	2.96
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.09	0.08	0.10	0.35	3.20	0.71
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.09	0.08	0.10	0.35	3.20	0.71
Net Current Assets	0.10	2.52	2.63	2.77	2.58	2.25
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.02	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.02	0.00	0.00	0.00	0.00	0.00
Total Assets	8.90	11.51	11.30	11.29	2.64	2.25
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.10	10.10	10.10	10.10	8.00	8.00
Reserves Total	13.11	14.07	3.59	2.46	-5.47	-5.88
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	23.21	24.17	13.69	12.56	2.53	2.12
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.95	10.32	16.39	11.28	0.20	0.13
Total Debt	0.95	10.32	16.39	11.28	0.20	0.13
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	24.16	34.49	30.08	23.84	2.73	2.25
APPLICATION OF FUNDS :
Gross Block	3.46	2.92	4.51	4.99	0.01	0.00
Less: Accumulated Depreciation	0.14	0.09	0.07	0.01	0.00	0.00
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	3.32	2.83	4.44	4.98	0.01	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.76	0.26	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.04	0.04	0.32	0.32	0.10
Sundry Debtors	9.85	12.79	11.67	14.62	3.46	0.59
Cash and Bank	7.42	15.41	6.98	1.47	0.30	0.02
Loans and Advances	2.81	9.98	3.85	6.27	2.24	2.25
Total Current Assets	20.08	38.23	22.54	22.67	6.32	2.96
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	4.01	6.23	7.58	11.14	3.58	0.71
Provisions	0.00	1.23	1.06	0.41	0.04	0.00
Total Current Liabilities	4.01	7.46	8.64	11.55	3.61	0.71
Net Current Assets	16.07	30.77	13.89	11.13	2.70	2.25
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.01	0.00	0.06	0.05	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	1.01	0.00	0.06	0.05	0.00	0.00
Other Assets	0.00	0.63	11.69	7.68	0.02	0.00
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.05	0.02	0.03	0.02	0.02
Net Cash from Operating Activities	-0.08	0.55	0.27	-0.01	0.04
Net Cash Used In Investing Activities	0.09	-0.38	-0.19	-0.07	-0.05
Net Cash Used In Financing Activities	0.00	-0.14	-0.09	0.09	0.01
Net Inc./Dec In Cash And Cash Equivalents	0.01	0.03	-0.01	0.01	-0.01
Cash And Cash Equivalents At End Of The Year	0.06	0.05	0.02	0.03	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

16.43%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

83.57%

**Promoter pledged shareholding 16.43%

About Decipher Labs Ltd

Decipher Labs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 16.07 crores. It has reported a sales of Rs. 0.17 crores and a net profit of Rs. 0.09 crores for the quarter ended December 2018. The company management includes , Sushant Mohan Lal,G Venkateswara Rao,Megha Agarwal (Decipher Labs Ltd) among others.

Chairman

Registered office

4th Flr Plot-94 Sagar Society,Banjara Hills Road No 2,Hyderabad,Telangana,500034

FAX :

Background

Incorporation Year1986

Face Value₹10

Market Lot100

How to buy Decipher Labs shares on nse?

To buy Decipher Labs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Decipher Labs share price today?

The Decipher Labs shares price on nse is Rs.15.91 today.

What is the market cap of Decipher Labs shares on BSE ?

The company has a market capitalization of Rs.16.07Cr

What is the PE & PB ratio of Decipher Labs shares ?

PE is 0 and PB is 1.85

What is the 52 Week High and Low of Decipher Labs shares?

Decipher Labs stock price high: Rs.25.75 Decipher Labs stock price low: Rs.14.5